<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03103763</url>
  </required_header>
  <id_info>
    <org_study_id>PenobscotBMC</org_study_id>
    <nct_id>NCT03103763</nct_id>
  </id_info>
  <brief_title>Anticoagulation Therapy in the Very Old</brief_title>
  <acronym>ATIVO</acronym>
  <official_title>ATIVO Study - Anticoagulation Therapy in the Very Old</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Robert W. Stein, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Penobscot Bay Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to evaluate the efficacy and safety of warfarin anticoagulation in the
      very old and attempt to identify risk factors which may impede safe and effective
      anticoagulation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective registry study with data being collected continuously for 24 months.

      Patients who have electrocardiographically confirmed atrial fibrillation, are being followed
      by the Pen Bay Medical Center Anticoagulation Services and are at least 90 years old will be
      recruited into the study. A matched cohort of patients between the ages of 80 and 89 and
      another matched cohort of patients between the ages of 70 and 79 will also be recruited into
      the study for comparison.

      Data related to adverse events, concomitant medications, living arrangements, mobility and
      alcohol use will be collected every 6 months. In addition the CHA2DS2-VASc (score for atrial
      fibrillation stroke risk), HAS - BLED (major bleeding risk score for patients on
      anticoagulation), frailty and Mini Cog scores will be recalculated at each visit.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 20, 2017</start_date>
  <completion_date type="Actual">September 3, 2019</completion_date>
  <primary_completion_date type="Actual">September 3, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Patients Experiencing Stroke</measure>
    <time_frame>24 months</time_frame>
    <description>Every 6 months the medical record was reviewed for evidence of stroke of any cause.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Patients Experiencing a Major Bleeding Event</measure>
    <time_frame>24 months</time_frame>
    <description>defined as one of the following: fatal bleeding, symptomatic bleeding in a critical area or organ or bleeding causing a fall in hemoglobin of 2 g/dl or more or leading to a transfusion of 2 or more units of whole blood or red cells</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Experiencing a Traumatic Subdural Hemorrhage</measure>
    <time_frame>24 months</time_frame>
    <description>Number of subjects who experienced a traumatic subdural hemorrhage in each age group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Experiencing a Traumatic Intracerebral Hemorrhage</measure>
    <time_frame>24 months</time_frame>
    <description>Number of subjects who experienced a traumatic intracerebral hemorrhage in each age group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Hospitalizations Patients Experienced</measure>
    <time_frame>24 months</time_frame>
    <description>Every 6 months the medical record was reviewed for any hospitalizations experienced by the subject within our healthcare system.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Experiencing Cardiovascular Death</measure>
    <time_frame>24 months</time_frame>
    <description>Every 6 months the medical record was reviewed. All deaths were researched for cause and noted if the cause was related to the cardiovascular system.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Experiencing Death Related to Anticoagulation</measure>
    <time_frame>24 months</time_frame>
    <description>All deaths were reviewed in the medical record to determine the cause and if it was related in any way to the use of anticoagulation therapy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Time in Therapeutic Range at End of Study Participation</measure>
    <time_frame>up to 24 months</time_frame>
    <description>International Normalized Ratio (INR) time in therapeutic range at the end of the individual's study participation.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">132</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Aged 90 and older</arm_group_label>
    <description>Subjects 90 years and older with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aged 80-89</arm_group_label>
    <description>Subjects aged 80-89 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aged 70-79</arm_group_label>
    <description>Subjects aged 70-79 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Warfarin</intervention_name>
    <description>Patients on warfarin for atrial fibrillation</description>
    <arm_group_label>Aged 70-79</arm_group_label>
    <arm_group_label>Aged 80-89</arm_group_label>
    <arm_group_label>Aged 90 and older</arm_group_label>
    <other_name>Coumadin, Jantoven</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients seen by the PBMC Anticoagulation Services who are taking warfarin, have atrial
        fibrillation aged 90 years and older will be invited to participate in the study. A matched
        cohort of patients aged 80-89 will also be enrolled as well as another matched cohort of
        patients aged 70-79 who are on warfarin for atrial fibrillation will be enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  70 years of age or older

          -  electrocardiographically confirmed atrial fibrillation

          -  anticipated regular follow up with patient by Penobscot Bay Medical Center (PBMC)
             Anticoagulation Services

          -  Subject or legally authorized representative must be willing to provide informed
             consent

        Exclusion Criteria:

        - Patients not being followed by the PBMC Anticoagulation Services
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert W. Stein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Penobscot Bay Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Penobscot Bay Medical Center</name>
      <address>
        <city>Rockport</city>
        <state>Maine</state>
        <zip>04856</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 1, 2017</study_first_submitted>
  <study_first_submitted_qc>April 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 6, 2017</study_first_posted>
  <results_first_submitted>April 5, 2020</results_first_submitted>
  <results_first_submitted_qc>June 3, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">June 16, 2020</results_first_posted>
  <last_update_submitted>June 3, 2020</last_update_submitted>
  <last_update_submitted_qc>June 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Penobscot Bay Medical Center</investigator_affiliation>
    <investigator_full_name>Robert W. Stein, MD</investigator_full_name>
    <investigator_title>Medical Director of Anticoagulation Services</investigator_title>
  </responsible_party>
  <keyword>Elderly</keyword>
  <keyword>Anticoagulation</keyword>
  <keyword>Risk Assessment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Warfarin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>date will not be shared</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 13, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT03103763/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 13, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT03103763/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 20, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT03103763/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Aged 90 and Older</title>
          <description>Subjects 90 years and older with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
        </group>
        <group group_id="P2">
          <title>Aged 80-89</title>
          <description>Subjects aged 80-89 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
        </group>
        <group group_id="P3">
          <title>Aged 70-79</title>
          <description>Subjects aged 70-79 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="44"/>
                <participants group_id="P3" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="36"/>
                <participants group_id="P3" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Aged 90 and Older</title>
          <description>Subjects 90 years and older with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
        </group>
        <group group_id="B2">
          <title>Aged 80-89</title>
          <description>Subjects aged 80-89 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
        </group>
        <group group_id="B3">
          <title>Aged 70-79</title>
          <description>Subjects aged 70-79 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="44"/>
            <count group_id="B2" value="44"/>
            <count group_id="B3" value="44"/>
            <count group_id="B4" value="132"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="44"/>
                    <measurement group_id="B4" value="132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="93" lower_limit="90" upper_limit="100"/>
                    <measurement group_id="B2" value="84" lower_limit="80" upper_limit="89"/>
                    <measurement group_id="B3" value="74" lower_limit="70" upper_limit="79"/>
                    <measurement group_id="B4" value="84" lower_limit="70" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="79"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="44"/>
                    <measurement group_id="B4" value="132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="44"/>
                    <measurement group_id="B4" value="132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Living at home alone</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Living at home with paid help</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Living at home with family</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="34"/>
                    <measurement group_id="B4" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Living in assisted living</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Living in Long Term Care</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients Experiencing Stroke</title>
        <description>Every 6 months the medical record was reviewed for evidence of stroke of any cause.</description>
        <time_frame>24 months</time_frame>
        <population>Three subjects in the 80-89 age group and two subjects in the 70-79 age group withdrew consent prior to end of study.</population>
        <group_list>
          <group group_id="O1">
            <title>Aged 90 and Older</title>
            <description>Subjects 90 years and older with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
          <group group_id="O2">
            <title>Aged 80-89</title>
            <description>Subjects aged 80-89 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
          <group group_id="O3">
            <title>Aged 70-79</title>
            <description>Subjects aged 70-79 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Experiencing Stroke</title>
          <description>Every 6 months the medical record was reviewed for evidence of stroke of any cause.</description>
          <population>Three subjects in the 80-89 age group and two subjects in the 70-79 age group withdrew consent prior to end of study.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients Experiencing a Major Bleeding Event</title>
        <description>defined as one of the following: fatal bleeding, symptomatic bleeding in a critical area or organ or bleeding causing a fall in hemoglobin of 2 g/dl or more or leading to a transfusion of 2 or more units of whole blood or red cells</description>
        <time_frame>24 months</time_frame>
        <population>Three subjects in the 80-89 age group and two subjects in the 70-79 age group withdrew consent prior to end of study.</population>
        <group_list>
          <group group_id="O1">
            <title>Aged 90 and Older</title>
            <description>Subjects 90 years and older with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
          <group group_id="O2">
            <title>Aged 80-89</title>
            <description>Subjects aged 80-89 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
          <group group_id="O3">
            <title>Aged 70-79</title>
            <description>Subjects aged 70-79 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Experiencing a Major Bleeding Event</title>
          <description>defined as one of the following: fatal bleeding, symptomatic bleeding in a critical area or organ or bleeding causing a fall in hemoglobin of 2 g/dl or more or leading to a transfusion of 2 or more units of whole blood or red cells</description>
          <population>Three subjects in the 80-89 age group and two subjects in the 70-79 age group withdrew consent prior to end of study.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Experiencing a Traumatic Subdural Hemorrhage</title>
        <description>Number of subjects who experienced a traumatic subdural hemorrhage in each age group</description>
        <time_frame>24 months</time_frame>
        <population>Three subjects in the 80-89 age group and two subjects in the 70-79 age group withdrew consent prior to end of study.</population>
        <group_list>
          <group group_id="O1">
            <title>Aged 90 and Older</title>
            <description>Subjects 90 years and older with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
          <group group_id="O2">
            <title>Aged 80-89</title>
            <description>Subjects aged 80-89 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
          <group group_id="O3">
            <title>Aged 70-79</title>
            <description>Subjects aged 70-79 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Experiencing a Traumatic Subdural Hemorrhage</title>
          <description>Number of subjects who experienced a traumatic subdural hemorrhage in each age group</description>
          <population>Three subjects in the 80-89 age group and two subjects in the 70-79 age group withdrew consent prior to end of study.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Experiencing a Traumatic Intracerebral Hemorrhage</title>
        <description>Number of subjects who experienced a traumatic intracerebral hemorrhage in each age group</description>
        <time_frame>24 months</time_frame>
        <population>Three subjects in the 80-89 age group and two subjects in the 70-79 age group withdrew consent prior to end of study.</population>
        <group_list>
          <group group_id="O1">
            <title>Aged 90 and Older</title>
            <description>Subjects 90 years and older with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
          <group group_id="O2">
            <title>Aged 80-89</title>
            <description>Subjects aged 80-89 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
          <group group_id="O3">
            <title>Aged 70-79</title>
            <description>Subjects aged 70-79 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Experiencing a Traumatic Intracerebral Hemorrhage</title>
          <description>Number of subjects who experienced a traumatic intracerebral hemorrhage in each age group</description>
          <population>Three subjects in the 80-89 age group and two subjects in the 70-79 age group withdrew consent prior to end of study.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Hospitalizations Patients Experienced</title>
        <description>Every 6 months the medical record was reviewed for any hospitalizations experienced by the subject within our healthcare system.</description>
        <time_frame>24 months</time_frame>
        <population>Three subjects in the 80-89 age group and two subjects in the 70-79 age group withdrew consent prior to end of study.</population>
        <group_list>
          <group group_id="O1">
            <title>Aged 90 and Older</title>
            <description>Subjects 90 years and older with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
          <group group_id="O2">
            <title>Aged 80-89</title>
            <description>Subjects aged 80-89 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
          <group group_id="O3">
            <title>Aged 70-79</title>
            <description>Subjects aged 70-79 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Hospitalizations Patients Experienced</title>
          <description>Every 6 months the medical record was reviewed for any hospitalizations experienced by the subject within our healthcare system.</description>
          <population>Three subjects in the 80-89 age group and two subjects in the 70-79 age group withdrew consent prior to end of study.</population>
          <units>hospitalizations</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                    <measurement group_id="O2" value="41"/>
                    <measurement group_id="O3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Experiencing Cardiovascular Death</title>
        <description>Every 6 months the medical record was reviewed. All deaths were researched for cause and noted if the cause was related to the cardiovascular system.</description>
        <time_frame>24 months</time_frame>
        <population>Three subjects in the 80-89 age group and two subjects in the 70-79 age group withdrew consent prior to end of study.</population>
        <group_list>
          <group group_id="O1">
            <title>Aged 90 and Older</title>
            <description>Subjects 90 years and older with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
          <group group_id="O2">
            <title>Aged 80-89</title>
            <description>Subjects aged 80-89 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
          <group group_id="O3">
            <title>Aged 70-79</title>
            <description>Subjects aged 70-79 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Experiencing Cardiovascular Death</title>
          <description>Every 6 months the medical record was reviewed. All deaths were researched for cause and noted if the cause was related to the cardiovascular system.</description>
          <population>Three subjects in the 80-89 age group and two subjects in the 70-79 age group withdrew consent prior to end of study.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Experiencing Death Related to Anticoagulation</title>
        <description>All deaths were reviewed in the medical record to determine the cause and if it was related in any way to the use of anticoagulation therapy.</description>
        <time_frame>24 months</time_frame>
        <population>Three subjects in the 80-89 age group and two subjects in the 70-79 age group withdrew consent prior to end of study.</population>
        <group_list>
          <group group_id="O1">
            <title>Aged 90 and Older</title>
            <description>Subjects 90 years and older with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
          <group group_id="O2">
            <title>Aged 80-89</title>
            <description>Subjects aged 80-89 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
          <group group_id="O3">
            <title>Aged 70-79</title>
            <description>Subjects aged 70-79 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Experiencing Death Related to Anticoagulation</title>
          <description>All deaths were reviewed in the medical record to determine the cause and if it was related in any way to the use of anticoagulation therapy.</description>
          <population>Three subjects in the 80-89 age group and two subjects in the 70-79 age group withdrew consent prior to end of study.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Time in Therapeutic Range at End of Study Participation</title>
        <description>International Normalized Ratio (INR) time in therapeutic range at the end of the individual's study participation.</description>
        <time_frame>up to 24 months</time_frame>
        <population>All subjects were included in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Aged 90 and Older</title>
            <description>Subjects 90 years and older with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
          <group group_id="O2">
            <title>Aged 80-89</title>
            <description>Subjects aged 80-89 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
          <group group_id="O3">
            <title>Aged 70-79</title>
            <description>Subjects aged 70-79 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Time in Therapeutic Range at End of Study Participation</title>
          <description>International Normalized Ratio (INR) time in therapeutic range at the end of the individual's study participation.</description>
          <population>All subjects were included in this analysis.</population>
          <units>percent of time in therapeutic range</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72" spread="17"/>
                    <measurement group_id="O2" value="76" spread="18"/>
                    <measurement group_id="O3" value="70" spread="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Because the study is a registry, no events were collected as adverse events. Outcomes were collected. All cause mortality was collected from date of consent up to 24 months.</time_frame>
      <desc>Death information was available. However, serious and other adverse event data were not monitored.</desc>
      <group_list>
        <group group_id="E1">
          <title>Aged 90 and Older</title>
          <description>Subjects 90 years and older with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
        </group>
        <group group_id="E2">
          <title>Aged 80-89</title>
          <description>Subjects aged 80-89 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
        </group>
        <group group_id="E3">
          <title>Aged 70-79</title>
          <description>Subjects aged 70-79 with atrial fibrillation, taking warfarin, followed by the Penobscot Bay Medical Center Anticoagulation Services.
Warfarin: Patients on warfarin for atrial fibrillation</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="41"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="42"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The small sample size limits the power of this study.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Caroline Knight, RN, Clinical Research Manager</name_or_title>
      <organization>Penobscot Bay Medical Center</organization>
      <phone>207-301-8959</phone>
      <email>cknight@pbmc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

